643 related articles for article (PubMed ID: 27387478)
1. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
[TBL] [Abstract][Full Text] [Related]
2. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
[TBL] [Abstract][Full Text] [Related]
4. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
[TBL] [Abstract][Full Text] [Related]
5. Intravenous tissue plasminogen activator for patients with minor ischemic stroke.
Huisa BN; Raman R; Neil W; Ernstrom K; Hemmen TM
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):732-6. PubMed ID: 21531576
[TBL] [Abstract][Full Text] [Related]
6. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
[TBL] [Abstract][Full Text] [Related]
7. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
Adeoye O; Knight WA; Khoury J; Schmit PA; Sucharew H; Broderick JP; Pancioli AM;
J Stroke Cerebrovasc Dis; 2014; 23(5):e313-5. PubMed ID: 24534128
[TBL] [Abstract][Full Text] [Related]
8. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
9. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
10. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
Guo C; Bai Q; Zhao Z; Zhang J
Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
[TBL] [Abstract][Full Text] [Related]
12. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
14. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
Yan X; Hu HT; Liu S; Sun YH; Gao X
Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
[TBL] [Abstract][Full Text] [Related]
15. Does symptom onset to primary stroke center time goals affect stroke outcome?
Chee B; Raman R; Ernstrom K; Guzik AK; Hemmen TM; Rapp KS; Meyer BC; Meyer DM
J Stroke Cerebrovasc Dis; 2014; 23(5):993-1000. PubMed ID: 24103670
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Pretnar Oblak J; Sabovic M; Frol S
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
[TBL] [Abstract][Full Text] [Related]
17. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
[TBL] [Abstract][Full Text] [Related]
18. Platelet-to-White Blood Cell Ratio: A Prognostic Predictor for 90-Day Outcomes in Ischemic Stroke Patients with Intravenous Thrombolysis.
Chen Z; Huang Y; Li S; Lin J; Liu W; Ding Z; Li X; Chen Y; Pang W; Yang D; Su Z; Li J; Weng Y; Zhang X
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2430-8. PubMed ID: 27372596
[TBL] [Abstract][Full Text] [Related]
19. Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients.
Spokoyny I; Raman R; Ernstrom K; Khatri P; Meyer DM; Hemmen TM; Meyer BC
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1276-81. PubMed ID: 25906938
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes after intravenous fibrinolysis in cryptogenic strokes with or without patent foramen ovale.
Chang JJ; Chiem T; Alderazi YJ; Chapple K; Restrepo L
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e492-9. PubMed ID: 23871701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
